The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Involvement of the Lateral Hypothalamic Peptide Orexin in Morphine Dependence and Withdrawal
Open accessAbstract
The lateral hypothalamus (LH) is implicated in the behavioral actions of drugs of abuse, but the cellular and molecular basis of this role is unclear. Recent identification of neuropeptides localized in LH neurons has allowed for more specific studies of LH function. The LH-specific peptide orexin (hypocretin) has been shown to be important in arousal and sleep regulation. However, orexin cells of the LH project broadly throughout the brain such that orexin may influence other behaviors as well. In this study, we show that orexin neurons, and not nearby LH neurons expressing melanin-concentrating hormone (MCH), have mu-opioid receptors and respond to chronic morphine administration and opiate antagonist-precipitated morphine withdrawal. cAMP response element-mediated transcription is induced in a subset of orexin cells, but not MCH cells, after exposure to chronic morphine or induction of withdrawal. Additionally, c-Fos and the orexin gene itself are induced in orexin cells in the LH during morphine withdrawal. Finally, we show that orexin knock-out mice develop attenuated morphine dependence, as indicated by a less severe antagonist-precipitated withdrawal syndrome. Together, these studies support a role for the orexin system in molecular adaptations to morphine, and demonstrate dramatic differences in molecular responses among different populations of LH neurons.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sakurai, T., Amemiya, A., Ishii, M., Matsuzaki, I., Chemelli, R. M., Tanaka, H., Williams, S. C., Richardson, J. A., Kozlowski, G. P., Wilson, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)80949-6 · Cited by 5,501
Self-citationNeurons containing hypocretin (orexin) project to multiple neuronal systems
Peyron, C., Tighe, D. K., van den Pol, A. N., de Lecea, L., Heller, H. C., Sutcliffe, J. G., & Kilduff, T. S. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-23-09996.1998 · Cited by 3,466
Olds, J., & Milner, P. (1954) · Journal of Comparative and Physiological Psychology · doi:10.1037/h0058775 · Cited by 3,176
Narcolepsy in orexin Knockout Mice
Chemelli, R. M., Willie, J. T., Sinton, C. M., Elmquist, J. K., Scammell, T., Lee, C., Richardson, J. A., Williams, S. C., Xiong, Y., Kisanuki, Y., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)81973-x · Cited by 3,095
Self-citationMolecular basis of long-term plasticity underlying addiction
Nestler, E. J. (2001) · Nature reviews. Neuroscience · doi:10.1038/35053570 · Cited by 1,893
Self-citationOrexin A activates locus coeruleus cell firing and increases arousal in the rat
Hagan, J. J., Leslie, R. A., Patel, S., Evans, M. L., Wattam, T. A., Holmes, S., Benham, C. D., Taylor, S. G., Routledge, C., Hemmati, P., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.19.10911 · Cited by 1,234
Hypothalamic control of food intake in rats and cats.
Anand, B. K., & Brobeck, J. R. (1951) · PubMed · Cited by 1,197
Mice lacking melanin-concentrating hormone are hypophagic and lean
Shimada, M., Tritos, N. A., Lowell, B. B., Flier, J. S., & Maratos–Flier, E. (1998) · Nature · doi:10.1038/25341 · Cited by 1,152
Sheng, M., McFadden, G., & Greenberg, M. E. (1990) · Neuron · doi:10.1016/0896-6273(90)90115-v · Cited by 1,076
Mansour, A., Khachaturian, H., Lewis, M. E. S., Akil, H., & Watson, S. J. (1988) · Pain · doi:10.1016/0304-3959(88)90103-0 · Cited by 973
Cited by
Sorted by citations
Items 101–200 of 374
Tobacco dependence, the insular cortex and the hypocretin connection
Kenny, P. J. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2010.08.015 · Cited by 69
Huang, H., Xu, Y., & van den Pol, A. N. (2011) · Journal of Neurophysiology · doi:10.1152/jn.00740.2010 · Cited by 70
Non-sleep effects of hypocretin/orexin
Samson, W. K., Taylor, M. M., & Ferguson, A. V. (2005) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2004.07.006 · Cited by 67
Zhou, Y., Cui, C., Schlussman, S. D., Choi, J. C., Ho, A., Han, J., & Kreek, M. J. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.03.023 · Cited by 67
Orexin Signaling in the VTA Gates Morphine-Induced Synaptic Plasticity
Baimel, C., & Borgland, S. L. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.4385-14.2015 · Cited by 68
Li, Y., Wang, H., Qi, K., Chen, X., Li, S., Sui, N., & Kirouac, G. J. (2010) · Physiology & Behavior · doi:10.1016/j.physbeh.2010.10.006 · Cited by 65
James, M. H., Fragale, J. E. C., Aurora, R. N., Cooperman, N. A., Langleben, D. D., & Aston‐Jones, G. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-0619-x · Cited by 64
Involvement of orexin in the regulation of stress, depression and reward in alcohol dependence
von der Goltz, C., Koopmann, A., Dinter, C., Richter, A., Grosshans, M., Fink, T., Wiedemann, K., & Kiefer, F. (2011) · Hormones and Behavior · doi:10.1016/j.yhbeh.2011.08.017 · Cited by 62
Ventral Tegmental Area Afferents and Drug-Dependent Behaviors
Oliva, I., & Wanat, M. J. (2016) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2016.00030 · Cited by 68
Orexin 1 receptor antagonists in compulsive behavior and anxiety: possible therapeutic use
Pich, E. M., & Melotto, S. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00026 · Cited by 66
Acute Pain and a Motivational Pathway in Adult Rats: Influence of Early Life Pain Experience
Low, L. A., & Fitzgerald, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034316 · Cited by 58
Orexin/Hypocretin Based Pharmacotherapies for the Treatment of Addiction: DORA or SORA?
Khoo, S. Y., & Brown, R. M. (2014) · CNS Drugs · doi:10.1007/s40263-014-0179-x · Cited by 62
Lateral thinking about leptin: A review of leptin action via the lateral hypothalamus
Leinninger, G. M. (2011) · Physiology & Behavior · doi:10.1016/j.physbeh.2011.04.060 · Cited by 62
Zhou, Y., Proudnikov, D., Yuferov, V., & Kreek, M. J. (2010) · Brain Research · doi:10.1016/j.brainres.2009.11.015 · Cited by 58
The Hypocretin/Orexin System: Implications for Drug Reward and Relapse
Plaza‐Zabala, A., Maldonado, R. J., & Berrendero, F. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8255-z · Cited by 58
Regulation of neurological and neuropsychiatric phenotypes by locus coeruleus-derived galanin
Weinshenker, D., & Holmes, P. V. (2015) · Brain Research · doi:10.1016/j.brainres.2015.11.025 · Cited by 63
Learning and the motivation to eat: forebrain circuitry.
Petrovich, G. D. (2011) · Physiology & Behavior · doi:10.1016/j.physbeh.2011.04.059 · Cited by 57
Sleep disturbance as a therapeutic target to improve opioid use disorder treatment.
Huhn, A. S., & Finan, P. H. (2021) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000477 · Cited by 60
Cornish, J. L., Hunt, G. E., Robins, L., & McGregor, I. S. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.01.004 · Cited by 59
Steiner, M. A., Lecourt, H., & Jenck, F. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712000193 · Cited by 56
Bidirectional Dopaminergic Modulation of Excitatory Synaptic Transmission in Orexin Neurons
Alberto, C. O., Trask, R. B., Quinlan, M. E., & Hirasawa, M. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.1819-06.2006 · Cited by 58
RetractedLaorden, M. L., Ferenczi, S., Pintér-Kübler, B., González-Martín, L. L., Lasheras, M. C., Kovács, K. J., Milanés, M. V., & Núñez, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036871 · Cited by 55
Circadian alteration in neurobiology during protracted opiate withdrawal in rats
Li, S., Liu, L.-J., Jiang, W., Sun, L., Zhou, S., Foll, B. L., Zhang, X., Kosten, T. R., & Lü, L. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06941.x · Cited by 54
Ahmadi‐Soleimani, S. M., Azizi, H., Gompf, H. S., & Semnanian, S. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.08.024 · Cited by 54
Central functions of the orexinergic system
Zhang, X., Yu, L., Zhuang, Q., Zhu, J., & Wang, J. (2013) · Neuroscience Bulletin · doi:10.1007/s12264-012-1297-4 · Cited by 55
CSF Versus Serum Leptin in Narcolepsy: Is There an Effect of Hypocretin Deficiency?
Arnulf, I., Lin, L., Zhang, J., Russell, I. J., Ripley, B. A., Einen, M. A., Nevšímalová, S., Bassetti, C. L., Bourgin, P., Nishino, S., et al. (2006) · SLEEP · doi:10.1093/sleep/29.8.1017 · Cited by 53
Nucleus incertus Orexin2 receptors mediate alcohol seeking in rats
Kastman, H. E., Błasiak, A., Walker, L. C., Siwiec, M., Krstew, E., Gundlach, A. L., & Lawrence, A. J. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.07.006 · Cited by 53
Azizi, H., Mirnajafi‐Zadeh, J., Rohampour, K., & Semnanian, S. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.07.050 · Cited by 52
Orexin Reserve: A Mechanistic Framework for the Role of Orexins (Hypocretins) in Addiction
James, M. H., & Aston‐Jones, G. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2022.06.027 · Cited by 51
Regulation of alcohol-seeking by orexin (hypocretin) neurons
Lawrence, A. J. (2009) · Brain Research · doi:10.1016/j.brainres.2009.07.072 · Cited by 50
Function and Dysfunction of Hypocretin/Orexin: An Energetics Point of View
Gao, X., & Horváth, T. L. (2014) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-071013-013855 · Cited by 50
Endogenous opiates and behavior: 2003
Bodnar, R. J., & Klein, G. E. (2004) · Peptides · doi:10.1016/j.peptides.2004.09.005 · Cited by 49
The hypocretins and the reward function: what have we learned so far?
Boutrel, B., Steiner, N., & Halfon, O. (2013) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2013.00059 · Cited by 48
Ten-Blanco, M., Flores, Á., Cristino, L., Pereda-Pérez, I., & Berrendero, F. (2023) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2023.101066 · Cited by 48
Lesions of orexin neurons block conditioned place preference for sexual behavior in male rats
Sebastiano, A. R. D., Wilson, H., Lehman, M. N., & Coolen, L. M. (2010) · Hormones and Behavior · doi:10.1016/j.yhbeh.2010.09.006 · Cited by 48
Erami, E., Azhdari‐Zarmehri, H., Rahmani, A., Ghasemi-Dashkhasan, E., Semnanian, S., & Haghparast, A. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.08.010 · Cited by 46
Rao, Y., Mineur, Y. S., Gan, G., Wang, A. H., Liu, Z., Wu, X., Suyama, S., de Lecea, L., Horváth, T. L., Picciotto, M. R., et al. (2013) · The Journal of Physiology · doi:10.1113/jphysiol.2012.246983 · Cited by 45
Luster, B. R., Cogan, E. S., Schmidt, K. T., Pati, D., Pina, M. M., Dange, K., & McElligott, Z. A. (2019) · Addiction Biology · doi:10.1111/adb.12748 · Cited by 45
The Hypocretin System and Psychiatric Disorders
Pizza, F., Magnani, M., Indrio, C., & Plazzi, G. (2013) · Current Psychiatry Reports · doi:10.1007/s11920-013-0433-9 · Cited by 46
Barateau, L., Jaussent, I., Lopez, R., Boutrel, B., Leu‐Semenescu, S., Arnulf, I., & Dauvilliers, Y. A. (2016) · SLEEP · doi:10.5665/sleep.5530 · Cited by 45
The Role of Orexins/Hypocretins in Alcohol Use and Abuse
Walker, L. C., & Lawrence, A. J. (2016) · Current topics in behavioral neurosciences · doi:10.1007/7854_2016_55 · Cited by 43
The potential role of the orexin reward system in future treatments for opioid drug abuse
Zarrabian, S., Riahi, E., Karimi, S., Razavi, Y., & Haghparast, A. (2018) · Brain Research · doi:10.1016/j.brainres.2018.11.023 · Cited by 43
Heifetz, A., Morris, G. B., Biggin, P. C., Barker, O., Fryatt, T., Bentley, J. M., Hallett, D. J., Manikowski, D., Pal, S., Reifegerste, R., et al. (2012) · Biochemistry · doi:10.1021/bi300136h · Cited by 42
Tabaeizadeh, M., Motiei-Langroudi, R., Mirbaha, H., Esmaeili, B., Tahsili‐Fahadan, P., Paydar, M. J., Ghaffarpour, M., & Dehpour, A. R. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.09.010 · Cited by 42
Farahimanesh, S., Zarrabian, S., & Haghparast, A. (2017) · Neuropeptides · doi:10.1016/j.npep.2017.08.003 · Cited by 41
The Insomnia-Addiction Positive Feedback Loop: Role of the Orexin System
Fragale, J. E. C., James, M. H., Avila, J. A., Spaeth, A. M., Aurora, R. N., Langleben, D. D., & Aston‐Jones, G. (2021) · Monographs in clinical neuroscience/Frontiers of neurology and neuroscience/Monographs in neural sciences · doi:10.1159/000514965 · Cited by 43
Modulation of trigeminovascular processing: Novel insights into primary headache disorders
Holland, P. R. (2009) · Cephalalgia · doi:10.1111/j.1468-2982.2009.02027.x · Cited by 42
Modulation of cellular activity and synaptic transmission in the ventral tegmental area
Mathon, D. S., Kamal, A., Smidt, M. P., & Ramakers, G. M. J. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.08.097 · Cited by 41
Mousavi, S. Y., Azizi, H., Mirnajafi‐Zadeh, J., Javan, M., & Semnanian, S. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.06.038 · Cited by 41
Chemistry and biology of orexin signaling
Kodadek, T. J., & Cai, D. (2010) · Molecular BioSystems · doi:10.1039/c003468a · Cited by 41
Hypocretin modulation of drug-induced synaptic plasticity
Baimel, C., & Borgland, S. L. (2012) · Progress in brain research · doi:10.1016/b978-0-444-59489-1.00008-2 · Cited by 40
Ahmadi‐Soleimani, S. M., Ghaemi-Jandabi, M., Azizi, H., & Semnanian, S. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.10.064 · Cited by 39
Qi, K., Wei, C., Li, Y., & Sui, N. (2013) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2013.00144 · Cited by 40
Hypocretin/orexin knock‐out mice display disrupted behavioral and dopamine responses to cocaine
Shaw, J. K., Ferris, M. J., Locke, J. L., Brodnik, Z. D., Jones, S. R., & España, R. A. (2016) · Addiction Biology · doi:10.1111/adb.12432 · Cited by 39
López-Muciño, L. A., García‐García, F., Cueto‐Escobedo, J., Acosta-Hernández, M. E., Venebra-Muñoz, A., & Rodríguez‐Alba, J. C. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104832 · Cited by 41
Guo, S.-J., Cui, Y., Huang, Z.-Z., Liu, H., Zhang, X., Jiang, J., & Xin, W. (2015) · Addiction Biology · doi:10.1111/adb.12236 · Cited by 39
Neuroscience of opiates for addiction medicine
Zhou, Y., & Leri, F. (2015) · Progress in brain research · doi:10.1016/bs.pbr.2015.09.001 · Cited by 37
Lavigne, G. J., Smith, M. T., Denis, R., & Zucconi, M. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-6645-3.00126-2 · Cited by 38
Esmaili‐Shahzade‐Ali‐Akbari, P., Hosseinzadeh, H., & Mehri, S. (2021) · NeuroToxicology · doi:10.1016/j.neuro.2021.02.005 · Cited by 37
Rehni, A. K., Bhateja, P. K., Singh, T. G., & Singh, N. (2008) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3282febcd9 · Cited by 38
Huan, S., Lei, C., Yuan, Y., Fu, Y., Cui, D., Li, Y., Shao, D., Cao, Z., Yang, H., Guo, X., et al. (2023) · Nature Communications · doi:10.1038/s41467-022-35758-5 · Cited by 38
Graebner, A. K., Iyer, M., & Carter, M. E. (2015) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2015.00111 · Cited by 37
Mori, K., Kim, J., & Sasaki, K. (2010) · Peptides · doi:10.1016/j.peptides.2010.10.023 · Cited by 37
Latifi, B., Adamantidis, A., Bassetti, C. L., & Schmidt, M. H. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00790 · Cited by 35
Nagase, H., Yamamoto, N., Yata, M., Ohrui, S., Okada, T., Saitoh, T., Kutsumura, N., Nagumo, Y., Irukayama‐Tomobe, Y., Ishikawa, Y., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01418 · Cited by 34
Self-citationMatzeu, A., & Martin‐Fardon, R. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107906 · Cited by 36
Leri, F., Zhou, Y., Goddard, B., Levy, A., Jacklin, D. L., & Kreek, M. J. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2008.09.004 · Cited by 35
Reece, A. S., Wang, W., & Hulse, G. K. (2018) · Medical Hypotheses · doi:10.1016/j.mehy.2018.04.011 · Cited by 34
Ranjbar‐Slamloo, Y., Azizi, H., Fathollahi, Y., & Semnanian, S. (2012) · Peptides · doi:10.1016/j.peptides.2012.02.023 · Cited by 34
Hypocretin/orexin deficiency decreases cocaine abuse liability
Steiner, N., Rossetti, C., Sakurai, T., Yanagisawa, M., de Lecea, L., Magistretti, P. J., Halfon, O., & Boutrel, B. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.02.010 · Cited by 36
Self-citationMatzeu, A., & Martin‐Fardon, R. (2022) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2021.787595 · Cited by 35
Orexin and MCH neurons: regulators of sleep and metabolism
Bouâouda, H., & Jha, P. K. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1230428 · Cited by 35
Intracoerulear microinjection of orexin-A induces morphine withdrawal-like signs in rats
Ghaemi-Jandabi, M., Azizi, H., Ahmadi‐Soleimani, S. M., & Semnanian, S. (2017) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2017.01.010 · Cited by 33
Dysregulation of the orexinergic system: A potential neuropeptide target in depression
Khairuddin, S., Aquili, L., Heng, B. C., Hoo, T. L. C., Wong, K.-H., & Lim, L. W. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.07.040 · Cited by 35
Further insights into the neurobiology of melanin-concentrating hormone in energy and mood balances
Hervieu, G. J. (2006) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.10.2.211 · Cited by 33
Orquestic regulation of neurotransmitters on reward-seeking behavior
Arias-Carrión, Ó., Caraza-Santiago, X., Salgado-Licona, S., Salama, M., Machado, S. E. D. C., Nardi, A. E., Menéndez‐González, M., & Murillo‐Rodríguez, E. (2014) · International Archives of Medicine · doi:10.1186/1755-7682-7-29 · Cited by 37
Oxycodone: A Current Perspective on Its Pharmacology, Abuse, and Pharmacotherapeutic Developments
Barrett, J. E., Shekarabi, A., & Inan, S. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000506 · Cited by 35
Zhou, Y., Leri, F., Cummins, E., & Kreek, M. J. (2014) · Physiology & Behavior · doi:10.1016/j.physbeh.2014.11.002 · Cited by 32
Integrative Physiology of Orexins and Orexin Receptors
Mieda, M., & Sakurai, T. (2009) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152709788921663 · Cited by 32
Self-citationNishizawa, D., Kasai, S., Hasegawa, J., Sato, N., Yamada, H., Tanioka, F., Nagashima, M., Katoh, R., Satoh, Y., Tagami, M., et al. (2015) · Molecular Brain · doi:10.1186/s13041-015-0142-x · Cited by 34
Gao, X., & Hermes, G. (2015) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2015.00142 · Cited by 31
Peptidomics of Cpefat/fat Mouse Hypothalamus and Striatum: Effect of Chronic Morphine Administration
Décaillot, F. M., Che, F., Fricker, L. D., & Devi, L. A. (2006) · Journal of Molecular Neuroscience · doi:10.1385/jmn:28:3:277 · Cited by 30
Ghaemi-Jandabi, M., Azizi, H., & Semnanian, S. (2014) · Brain Research · doi:10.1016/j.brainres.2014.06.033 · Cited by 29
Alizamini, M. M., Farzinpour, Z., Ezzatpanah, S., & Haghparast, A. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.09.007 · Cited by 29
The hypocretin/orexin system as a target for excessive motivation in alcohol use disorders
Moorman, D. E. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4871-2 · Cited by 31
Identification of discrete, intermingled hypocretin neuronal populations
Iyer, M., Essner, R. A., Klingenberg, B., & Carter, M. E. (2018) · The Journal of Comparative Neurology · doi:10.1002/cne.24490 · Cited by 27
Characterization of the intergenerational impact of in utero and postnatal oxycodone exposure
Odegaard, K. E., Schaal, V. L., Clark, A. R., Koul, S., Gowen, A. M., Sankarasubramanian, J., Xiao, P., Guda, C., Lisco, S. J., Yelamanchili, S. V., et al. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-01012-z · Cited by 31
James, M. H., Fragale, J. E. C., O’Connor, S. L., Zimmer, B. A., & Aston‐Jones, G. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108359 · Cited by 30
Azhdari‐Zarmehri, H., Esmaeili, M. H., Sofiabadi, M., & Haghdoost-Yazdi, H. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.09.018 · Cited by 29
Hypocretin mechanisms in nicotine addiction: evidence and speculation
Corrigall, W. A. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1588-2 · Cited by 29
Orexinergic Input to Dopaminergic Neurons of the Human Ventral Tegmental Area
Hrabovszky, E., Molnár, C. S., Borsay, B. Á., Gergely, P. A., Herczeg, L., & Liposits, Z. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083029 · Cited by 33
Sadeghzadeh, F., Namvar, P., Naghavi, F. S., & Haghparast, A. (2015) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2015.12.005 · Cited by 28
Wu, M., Li, Z., Liang, L., Ma, P., Cui, D., Chen, P., Wu, G., & Song, X. (2019) · Pain · doi:10.1097/j.pain.0000000000001738 · Cited by 29
Bidirectional translational research: Progress in understanding addictive diseases
Kreek, M. J., Schlussman, S. D., Reed, B., Zhang, Y., Nielsen, D. A., Levran, O., Zhou, Y., & Butelman, E. R. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.07.042 · Cited by 28
Tran, D., Bonaventure, P., Hack, M. D., Mirzadegan, T., Dvorak, C. A., Letavic, M. A., Carruthers, N. I., Lovenberg, T. W., & Sutton, S. W. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.05.074 · Cited by 27
McPherson, C. S., Featherby, T. J., Krstew, E., & Andrew, J. L. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.125732 · Cited by 29
Abdollahi, H., Ghaemi-Jandabi, M., Azizi, H., & Semnanian, S. (2016) · Brain Research · doi:10.1016/j.brainres.2016.05.043 · Cited by 27
Dunigan, A. I., & Roseberry, A. G. (2022) · Addiction Neuroscience · doi:10.1016/j.addicn.2022.100011 · Cited by 28
Future perspectives of emerging novel drug targets and immunotherapies to control drug addiction
Malik, J. A., & Agrewala, J. N. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110210 · Cited by 32
Nonpeptide Orexin-2 Receptor Agonist Attenuates Morphine-induced Sedative Effects in Rats
Toyama, S., Shimoyama, N., Tagaito, Y., Nagase, H., Saitoh, T., Yanagisawa, M., & Shimoyama, M. (2018) · Anesthesiology · doi:10.1097/aln.0000000000002161 · Cited by 26
Self-citation
Metadata
- Authors
- Georgescu, D., Zachariou, V., Barrot, M., Mieda, M., Willie, J. T., Eisch, A. J., Yanagisawa, M., Nestler, E. J., & DiLeone, R. J.
- Affiliations
- Howard Hughes Medical Institute (US)
- The University of Texas Southwestern Medical Center (US)
- Centre National de la Recherche Scientifique (FR)
- ORCID
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2003-04-15
- Volume
- 23
- Issue
- 8
- Pages
- 3106-3111
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC6742290
- OpenAlex
- W2099485542
- Cited by
- 373
- References
- 46
- Citations by year
- 2026: 4 · 2025: 11 · 2024: 16 · 2023: 15 · 2022: 16 · 2021: 12 · 2020: 18 · 2019: 10 · 2018: 20 · 2017: 10 · 2016: 20 · 2015: 15 · 2014: 19 · 2013: 19 · 2012: 27
- FWCI
- 4.17
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Neuroscience (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institutes of Health
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Cognitive Neuroscience › Sleep and Wakefulness Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- orexin, lateral hypothalamus, morphine dependence, morphine withdrawal, mu-opioid receptor, melanin-concentrating hormone, cAMP response element, c-fos, orexin knockout mice, opioid use disorder, neuronal gene expression
- MeSH terms
- Orexins, Animals, Carrier Proteins, Chronic Disease, Disease Models, Animal, Drug Implants, Gene Expression Regulation, Homozygote, Hypothalamic Hormones, Hypothalamus, Lac Operon, Male, Melanins, Mice, Transgenic, Morphine, Morphine Dependence, Motor Activity, Neurons, Neuropeptides, Pituitary Hormones, Substance Withdrawal Syndrome, Proto-Oncogene Proteins c-fos, Receptors, Opioid, mu, Genes, Reporter, Receptors, Neuropeptide, Mice, Knockout, Response Elements, Receptors, G-Protein-Coupled, Intracellular Signaling Peptides and Proteins, Mice, Orexin Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
